These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33508838)

  • 1. Hepatitis B Vaccination Response in Hemodialysis Patients: The Impact of Dialysis Shift.
    Han M; Ye X; Rao S; Williams S; Thijssen S; Hymes J; Maddux FW; Kotanko P
    Blood Purif; 2021; 50(4-5):628-635. PubMed ID: 33508838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study.
    Mettang T; Schenk U; Thomas S; Machleidt C; Kiefer T; Fischer FP; Kuhlmann U
    Nephron; 1996; 72(2):192-6. PubMed ID: 8684526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a hepatitis B vaccination program at two tertiary hemodialysis centers.
    Kufta L; Shalansky KF; Jastrzebski J; Lau W
    Hemodial Int; 2019 Jul; 23(3):348-355. PubMed ID: 31119863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
    Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].
    Polito P; Di Lullo L; Iannacci GR; Cecilia A; Galderisi C; Gorini A
    G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines.
    Coates T; Wilson R; Patrick G; André F; Watson V
    Clin Ther; 2001 Mar; 23(3):392-403. PubMed ID: 11318074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?
    Jadoul M; Goubau P
    Clin Nephrol; 2002 Oct; 58(4):301-4. PubMed ID: 12400846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
    Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
    Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination in haemodialysis patients: an underestimated problem. Factors influencing immune responses in ten years of observation in an Italian haemodialysis centre and literature review.
    Cordova E; Miglia I; Festuccia F; Sarlo MG; Scornavacca G; Punzo G; Menè P; Fofi C
    Ann Ig; 2017; 29(1):27-37. PubMed ID: 28067935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial.
    Chow KM; Lo SH; Szeto CC; Yuen SK; Wong KS; Kwan BC; Leung CB; Li PK
    Nephrol Dial Transplant; 2010 Jul; 25(7):2303-9. PubMed ID: 20185409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.
    Misurac JM; VanDeVoorde RG; Kallash M; Iorember FM; Luckritz KE; Rheault MN; Jetton JG; Turman MA; Kapur G; Twombley KE; Hashmat S; Weaver DJ; Leiser JD; Nailescu C
    Clin J Am Soc Nephrol; 2017 May; 12(5):772-778. PubMed ID: 28270432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B
    Elhanan E; Boaz M; Schwartz I; Schwartz D; Chernin G; Soetendorp H; Gal Oz A; Agbaria A; Weinstein T
    Clin Exp Nephrol; 2018 Feb; 22(1):151-158. PubMed ID: 28456864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
    Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
    Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
    Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response.
    Peces R; Laurés AS
    Nephron; 2001 Oct; 89(2):172-6. PubMed ID: 11549899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP; Mandal SK; Thakur A; Kapoor D; Anuradha S; Prakash A; Kohli R; Agarwal SK
    Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.